Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria

Muhamed-Kheir Taha1, Maria Leticia Zarantonelli, Arianna Neri

  • 1Neisseria Unit and French National Reference Center for Meningococci, Institut Pasteur, 28 Rue du Dr Roux, Paris, France. mktaha@pasteur.fr

Insights

Genotyping the penA gene accurately predicts Neisseria meningitidis susceptibility to penicillin G, even in culture-negative samples. This PCR-based method offers a rapid, reliable alternative for antimicrobial susceptibility testing.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Neisseria meningitidis is a significant cause of bacterial meningitis.
  • Accurate antimicrobial susceptibility testing is crucial for effective treatment.
  • Penicillin G remains a key antibiotic, but resistance is a concern.

Purpose of the Study:

  • To evaluate a nonculture method for detecting penicillin G susceptibility in Neisseria meningitidis.
  • To assess the correlation between penA gene genotyping and phenotypic susceptibility testing.
  • To determine the utility of PCR-based penA genotyping for culture-negative samples.

Main Methods:

  • Multi-laboratory study involving 13 clinical cerebrospinal fluid samples and isolates.
  • Determination of penicillin G Minimum Inhibitory Concentrations (MICs) for isolates.
  • In-house PCR-based genotyping of the penA gene and nucleotide sequencing.

Main Results:

  • Good correlation observed between penA genotyping and phenotypic penicillin G susceptibility (MICs).
  • PCR results for penA showed high agreement (kappa coefficient 0.65-1) with isolate data and sequence analysis.
  • Genotyping successfully predicted antimicrobial susceptibility in both isolates and clinical samples.

Conclusions:

  • PenA gene genotyping is a reliable method for predicting Neisseria meningitidis susceptibility to penicillin G.
  • PCR-based genotyping offers a rapid and cost-effective approach for large-scale testing.
  • Genotyping is particularly valuable for determining susceptibility in culture-negative cases, guiding antimicrobial therapy.

Related Concept Videos